| Financial Year |
March 31 2023 |
| Monetary Funds |
55,880,584.82 |
| Held-for-trading Financial Assets |
604,476.64 |
| Notes Receivable |
24,508,398.15 |
| Accounts Receivable |
190,947,806.52 |
| Advances to Suppliers |
11,101,631.88 |
| Other Receivables |
31,980,359.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
521,298,251.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,518,882.02 |
| Total Current Assets |
873,354,438.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,899,800.02 |
| Long-term Equity Investment |
27,909,752.92 |
| Investment Properties |
-- |
| Fixed Assetes |
57,418,636.18 |
| Under-construction Projects |
63,866,752.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,946,530.60 |
| R&D expenses |
-- |
| Goodwill |
169,012,625.43 |
| Long-Term Deferred and Prepaid Expenses |
1,598,073.93 |
| Deferred Income Tax Assets |
99,940,858.45 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
523,811,093.38 |
| Total Assets |
1,397,165,532.24 |
| Short-Term Loans |
186,862,142.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,890,117.10 |
| Accounts Payable |
309,685,061.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,209,019.12 |
| Taxes Payable |
12,624,711.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,645,145.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,070,770.69 |
| Other Current Liabilities |
40,480,334.05 |
| Sub-Total of Current Liabilities |
861,886,583.94 |
| Long-term Loans |
33,222,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,054,190.55 |
| Deferred Income Tax Liabilities |
2,098,036.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
41,374,227.29 |
| Total Liabilities |
903,260,811.23 |
| Paid-In Capital(Or Share Stock) |
288,549,669.00 |
| Capital Surplus |
1,285,623,912.19 |
| Surplus Reserve |
38,773,362.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,131,029,473.67 |
| Minority Stockholder's Interest |
11,988,035.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
481,916,685.80 |
| Owner's Equity（Stockholder's Equity） |
493,904,721.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,397,165,532.24 |
